News and Press - JDRF T1D Fund

IM Therapeutics Launches Phase 1b Trial of Lead Drug IMT-002 in Autoimmunity; Announces Positive Safety Data of Phase 1a Study

October 29, 2020 | WOBURN, MA

How Disease-Focused Venture Philanthropy Can Accelerate Cures

October 22, 2020

A Venture Philanthropy Fund Yields Big Results in the Battle Against Diabetes

October 16, 2020

Sonoma Biotherapeutics Expands Series A Financing to $70 Million and Appoints Key Executives to Advance Regulatory T-cell Therapies in Autoimmune and Degenerative Diseases

September 30, 2020 | SOUTH SAN FRANCISCO, CA

Veralox Therapeutics Appoints Life Sciences Industry Veteran Alex Martin as Chairman of the Board of Directors

September 17, 2020 | FREDERICK, MD